Is the price fair?
What CAH's price assumes
Today's price asks for −4.4% free cash flow growth a year; over the last three years Cardinal Health delivered 25%, less than the record.
0.20
Price / sales · no P/E: the last twelve months did not end in a profit
- Free cash flow yield
- 11%
Free cash flow yield · Healthcare median 4.7%
- Growth the price implies
- −4.4%
Growth the price implies · The price pays for −4.4% free cash flow growth a year for a decade; the business has delivered +25% a year over the last three.
Details›
- EV / EBIToperating margin 1.0%: the multiple describes the denominator
- not meaningful
- Free cash flow, trailing twelve months
- $5.50B
- Market capitalisation
- $51.9B
- 3-year revenue growth
- +8.2%
- 3-year free cash flow growth
- +25%
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Healthcare
Ranks #70 of 345 by Smart Score